Explore

Rapid ReadRapid Read
Researchers Propose Framework to Standardize Ayurvedic Clinical Trial Protocols

Researchers Propose Framework to Standardize Ayurvedic Clinical Trial Protocols

A team of researchers, including Satyajit Pandurang Kulkarni, Bharat Rathi, Shweta Parwe, and Pallavi Kulkarni, has introduced a methodological framework and eleven candidate reporting extensions aimed at standardizing clinical trial protocols for Ayurvedic whole-system interventions. This proposal builds upon the EQUATOR Network guideline development process, seeking to integrate principles of reproducibility, transparency, and open science into Ayurvedic research. The initiative addresses long-standing challenges in applying conventional protocol reporting frameworks to individualized, multi-modal interventions characteristic of Ayurveda. While the updated SPIRIT 2025 statement includes an open-science section with 34 minimum protocol items, its applicability to the multi-modal logic of Ayurvedic research has been unclear. The proposed framework specifically examines how these open-science provisions can be systematically operationalized within Ayurvedic clinical trials. The candidate extensions are desi...
Rapid ReadRapid Read
National Multiple Sclerosis Society Funds Research for Earlier MS Detection

National Multiple Sclerosis Society Funds Research for Earlier MS Detection

The National Multiple Sclerosis Society has launched a new funding initiative aimed at improving the early detection of multiple sclerosis (MS). This program seeks to support the development and validation of screening methods that are scalable, clinically practical, and cost-effective. The goal is to identify individuals who require a comprehensive neurological evaluation for MS in various healthcare settings. Early detection is crucial because MS damages myelin, the protective coating around nerve cells, which can disrupt nerve signals. Symptoms can vary widely among individuals and may include vision changes, numbness, weakness, stiffness, balance issues, bladder problems, fatigue, and cognitive difficulties. There is no single test for MS; diagnosis typically involves a combination of patient history, neurological exams, MRI scans of the brain and spinal cord, blood tests to rule out other conditions, and sometimes a lumbar puncture. The initiative underscores the importance of identifying the disease ...
TrendlineTrendline
Organon to Present New Analysis on VTAMA® (tapinarof) Cream for Atopic Dermatitis at ACAAI Meeting

Organon to Present New Analysis on VTAMA® (tapinarof) Cream for Atopic Dermatitis at ACAAI Meeting

Organon to Present New Analysis on VTAMA® (tapinarof) Cream for Atopic Dermatitis at ACAAI Meeting
Rapid ReadRapid Read
FDA's New Rare Disease Framework Initiative Hailed as 'Quantum Leap' for Patient Community

FDA's New Rare Disease Framework Initiative Hailed as 'Quantum Leap' for Patient Community

The U.S. Food and Drug Administration (FDA) has launched a new Rare Disease Framework Initiative, which is being widely recognized as a significant advancement for the rare disease community. This initiative follows years of advocacy from patients, caregivers, and organizations like The LAM Foundation, who have consistently shared their experiences and needs. The framework aims to address critical challenges inherent in rare diseases, such as small patient populations, limited understanding of disease progression, and difficulties in measuring treatment effectiveness. The LAM Foundation has expressed strong support for this new effort, highlighting its potential to foster greater collaboration among patients, researchers, clinicians, and regulators. The organization plans to actively participate in the public comment process, contributing insights from its community of women and families affected by rare conditions. This initiative signifies a pivotal moment where patient voices are being formally integrat...
Rapid ReadRapid Read
NIH Funding Cuts Lead to Financial Strain and Staff Reductions at Clinical Research Sites

NIH Funding Cuts Lead to Financial Strain and Staff Reductions at Clinical Research Sites

Clinical research sites are experiencing increased operational challenges, with trial complexity identified as the top problem by 41% of sites, up from 35% a year ago. Two-thirds of sites report their teams are overloaded or at risk of burnout, and less than a third find their current workload sustainable, according to WCG’s fourth annual Clinical Research Site Challenges Report. Protocol design is a primary source of difficulty, with 66% of sites rating protocol complexity as a high driver of overall trial difficulty. Sponsor-driven design changes lead to amendments at 78% of sites, consuming a significant portion of study start-up time. Furthermore, NIH funding cuts have exacerbated financial pressures, with nearly two-thirds of sites reporting negative impacts on their financial performance. In response, many sites have implemented hiring freezes or staff reductions, which further intensifies staffing strain, ranked second in the survey at 38%. Contract and budget delays also contribute significantly to...
Rapid ReadRapid Read
The BMJ Publishes Review on Shockwave Therapy for Frozen Shoulder, Highlighting Short-Term Pain Relief

The BMJ Publishes Review on Shockwave Therapy for Frozen Shoulder, Highlighting Short-Term Pain Relief

A review of the latest trial evidence, published by The BMJ, indicates that extracorporeal shockwave therapy (ESWT) likely reduces short-term pain associated with frozen shoulder. ESWT involves delivering low-energy sound waves to damaged tissue to stimulate blood flow and healing. The review, which analyzed 189 randomized controlled trials involving 12,988 adults with adhesive capsulitis (frozen shoulder), found moderate-certainty evidence for short-term pain reduction compared to usual care. While there were indications that ESWT might also improve short-term function, flexion, and abduction, these benefits are considered less certain due to low-certainty evidence and inconsistent data. The review also noted that manipulation under anesthesia, with or without steroid injections, probably improved short-term flexion.
Rapid ReadRapid Read
National Multiple Sclerosis Society Funds New Initiative for Earlier MS Detection

National Multiple Sclerosis Society Funds New Initiative for Earlier MS Detection

The National Multiple Sclerosis Society has launched a new funding opportunity aimed at accelerating the early detection of multiple sclerosis (MS). This initiative seeks to support the creation and validation of screening methods that are scalable, practical for clinical use, and cost-effective. The goal is to identify individuals who require comprehensive neurological evaluations across various healthcare settings. Currently, diagnosing MS involves magnetic resonance imaging (MRI), clinical assessments, and the McDonald diagnostic criteria. However, MS lacks a single definitive diagnostic test, and its symptoms can overlap with other conditions, necessitating thorough evaluation. The Society's new funding aims to overcome these diagnostic challenges by fostering innovative approaches to identify MS earlier.
Rapid ReadRapid Read
AI-Driven Automation Transforms Clinical Trial Setup, Reducing Timelines from Months to Days

AI-Driven Automation Transforms Clinical Trial Setup, Reducing Timelines from Months to Days

AI-driven automation is fundamentally changing the landscape of clinical trial setup, significantly reducing the time required for various tasks. Traditionally, processes like protocol drafting, form creation, database builds, and validation could take weeks or even months due to manual handoffs and sequential workflows. With AI, these tasks are now compressed into minutes or days through automated generation and intelligent configuration. This shift allows for a streamlined, parallel process that supports faster decision-making and earlier study execution. Beyond just time savings, this approach introduces new capabilities such as rapid study simulation and near-real-time analytics, enabling research teams to identify potential issues earlier and proceed with greater confidence. This transformation reallocates effort from repetitive build tasks towards enhancing study quality, oversight, and the patient experience, marking a significant advancement in clinical operations.
TrendlineTrendline
Clinical Research Sites Face Growing Strain from Trial Complexity, AI Integration Challenges

Clinical Research Sites Face Growing Strain from Trial Complexity, AI Integration Challenges

Clinical Research Sites Face Growing Strain from Trial Complexity, AI Integration Challenges
Rapid ReadRapid Read
Healthcare Sector Navigates AI Automation with Focus on Drudgery vs. Judgment Tasks

Healthcare Sector Navigates AI Automation with Focus on Drudgery vs. Judgment Tasks

The healthcare sector is strategically evaluating the implementation of AI automation by distinguishing between tasks that involve 'drudgery' and those requiring 'judgment.' A framework is being used to assess tasks based on how well AI performs them and the degree to which human judgment is necessary. Tasks where AI performs reliably and the manual work is repetitive and low-value, such as searching for values across documents or comparing data, are considered prime candidates for automation. This approach, exemplified by MRO's Prodigy™ for clinical data abstraction, aims to free healthcare professionals from tedious tasks, allowing them to focus on areas that genuinely require their expertise and critical thinking. Conversely, tasks where AI performs well but still necessitate human interpretation or decision-making, or where AI is not yet reliable, are kept under human oversight. The goal is not to eliminate human roles but to redefine them, shifting the focus from manual hunting to applying specialized...
TrendlineTrendline
Pfizer Medical Director Discusses AI's Role in Bridging Clinical Trial Data to Real-World Application

Pfizer Medical Director Discusses AI's Role in Bridging Clinical Trial Data to Real-World Application

Pfizer Medical Director Discusses AI's Role in Bridging Clinical Trial Data to Real-World Application
TrendlineTrendline
Longevity Doctor Raises Concerns Over Andrew Huberman's New Wellness Book, Citing Unsubstantiated Claims and Corporate Influence

Longevity Doctor Raises Concerns Over Andrew Huberman's New Wellness Book, Citing Unsubstantiated Claims and Corporate Influence

Longevity Doctor Raises Concerns Over Andrew Huberman's New Wellness Book, Citing Unsubstantiated Claims and Corporate Influence